Skip Nav Destination
Gut and Liver: Falk Symposium 174, Beijing, August 2010Available to Purchase
Edited by
S.Karger AG
Status:
Out of Print Available Online
ISBN electronic:
978-3-8055-9673-2
ISBN print:
978-3-8055-9672-5
Publication date:
2011
Book Details
A pathophysiological view on diagnosis and treatment
Gut and Liver: Falk Symposium 174, Beijing, August 2010
Edited by: C.-W. Chen, J. Cheng, P. Ginès, Q. Ouyang, J. Schölmerich
https://doi.org/10.1159/isbn.978-3-8055-9673-2
ISBN (print): 978-3-8055-9672-5
ISBN (electronic): 978-3-8055-9673-2
Publisher: S.Karger AG
Published: 2011
Download citation file:
Table of Contents
-
1 - 6: Inflammatory Bowel Disease Genetics around the WorldByJudy H. ChoJudy H. ChoIBD Center, Yale University, New Haven, Conn., USASearch for other works by this author on:
-
7 - 8: Modern Endoscopy and Radiology in the Diagnosis of Inflammatory Bowel DiseaseByZhi Hua RanZhi Hua RanDepartment of Gastroenterology, Renji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai Institute of Digestive Disease, Shanghai, ChinaSearch for other works by this author on:
-
9 - 20: Serological Markers in Inflammatory Bowel DiseaseByGerhard Rogler;Gerhard RogleraDivision of Gastroenterology and Hepatology, Department of Internal Medicine, University Hospital of Zurich, Zurich, Switzerland;Search for other works by this author on:Florian RiederFlorian RiederbDepartment of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USASearch for other works by this author on:
-
21 - 25: Stool Markers and Clinical Microbiology in the Diagnosis and Management of Inflammatory Bowel DiseasesByR. Balfour SartorR. Balfour SartorDivision of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, N.C., USASearch for other works by this author on:
-
26 - 30: New Insights into Inflammatory Bowel Disease Epidemiology – Are There any Lessons for Treatment?ByCharles N. BernsteinCharles N. BernsteinSection of Gastroenterology, University of Manitoba IBD Clinical and Research Centre, Winnipeg, Man., CanadaSearch for other works by this author on:
-
31 - 34: Oral/Rectal or Combination 5-Aminosalicylic Acid?ByPhilippe MarteauPhilippe MarteauMedico-Surgical Department of Digestive Diseases, AP-HP, Hôpital Lariboisière, Paris, FranceSearch for other works by this author on:
-
35 - 41: Ulcerative Colitis: The Choice of ImmunosuppressantByGerassimos J. MantzarisGerassimos J. MantzarisA’ Department of Gastroenterology, Evangelismos Hospital, Athens, GreeceSearch for other works by this author on:
-
42 - 47: When Is Surgery Indicated in Ulcerative Colitis?ByQin Ouyang;Qin OuyangDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, ChinaSearch for other works by this author on:Yan PanYan PanDepartment of Gastroenterology, West China Hospital, Sichuan University, Chengdu, ChinaSearch for other works by this author on:
-
48 - 55: Basic Treatment and Prediction of a Severe Course of Crohn’s DiseaseByMarcellus SimadibrataMarcellus SimadibrataDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, IndonesiaSearch for other works by this author on:
-
56 - 59: Choice of Immunosuppressive TherapyByToshifumi Hibi;Toshifumi HibiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, JapanSearch for other works by this author on:Tadakazu HisamatsuTadakazu HisamatsuDivision of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, JapanSearch for other works by this author on:
-
60 - 67: Surgical Options in Crohn’s DiseaseByE.J. Eshuis;E.J. EshuisaDepartments of Surgery andbGastroenterology and Hepatology, Academic Medical Center, Amsterdam, The NetherlandsSearch for other works by this author on:W.A. BemelmanW.A. BemelmanaDepartments of Surgery andSearch for other works by this author on:
-
68 - 71: What Should We Expect from Future Therapies for Inflammatory Bowel Disease?ByStephen B. HanauerStephen B. HanauerSection of Gastroenterology, Hepatology and Nutrition, University of Chicago, Chicago, Ill., USASearch for other works by this author on:
-
72 - 79: New Antiviral Therapies in the Management of Hepatitis C Virus InfectionByChristian Markus Lange;Christian Markus LangeDepartment of Medicine 1, Johann Wolfgang Goethe University, Frankfurt am Main, GermanySearch for other works by this author on:Christoph Sarrazin;Christoph SarrazinDepartment of Medicine 1, Johann Wolfgang Goethe University, Frankfurt am Main, GermanySearch for other works by this author on:Stefan ZeuzemStefan ZeuzemDepartment of Medicine 1, Johann Wolfgang Goethe University, Frankfurt am Main, GermanySearch for other works by this author on:
-
80 - 86: Acute-on-Chronic Liver Failure: Pathogenesis and DiagnosisByRichard MoreauRichard MoreauINSERM, U773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3, and Service d’Hépatologie, Hôpital Beaujon, Clichy, Université Denis Diderot, Paris 7, Site Bichat, Paris, FranceSearch for other works by this author on:
-
87 - 94: Cirrhotic Cardiomyopathy: Clinical Consequences and Pathogenic MechanismsByHongqun Liu;Hongqun LiuLiver Unit, University of Calgary, Calgary, Alta., CanadaSearch for other works by this author on:Samuel S. LeeSamuel S. LeeLiver Unit, University of Calgary, Calgary, Alta., CanadaSearch for other works by this author on:
-
95 - 101: Management of Chronic Hepatitis BByChing-Lung Lai;Ching-Lung LaiDepartment of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, SAR, ChinaSearch for other works by this author on:Man-Fung YuenMan-Fung YuenDepartment of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, SAR, ChinaSearch for other works by this author on:
-
102 - 112: Renal Dysfunction and Pathogenesis and Treatment of Ascites and Hepatorenal Syndrome in CirrhosisByVicente Arroyo;Vicente ArroyoLiver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, Barcelona, SpainSearch for other works by this author on:Javier FernándezJavier FernándezLiver Unit, Institute of Digestive and Metabolic Diseases, Hospital Clinic, University of Barcelona, Barcelona, SpainSearch for other works by this author on:
-
113 - 116: Chronic Liver Failure Management: Management of Bacterial InfectionsByKwang-Hyub HanKwang-Hyub HanLiver Cancer Special Clinic, Department of Internal Medicine, Yonsei University College of Medicine, Liver Cirrhosis Clinical Research Center, and Brain Korea 21 Project for Medical Science, Seoul, South KoreaSearch for other works by this author on:
-
117 - 122: Hepatic EncephalopathyByDieter HäussingerDieter HäussingerClinic for Gastroenterology, Hepatology, and Infectiology, Heinrich Heine University Düsseldorf, Düsseldorf, GermanySearch for other works by this author on:
-
123 - 126: Antiviral Therapy in Decompensated Cirrhosis due to Hepatitis B VirusByQingchun Fu;Qingchun FuShanghai Liver Disease Research Center of Nanjing Military Command, Shanghai, ChinaSearch for other works by this author on:Chengwei ChenChengwei ChenShanghai Liver Disease Research Center of Nanjing Military Command, Shanghai, ChinaSearch for other works by this author on:
-
127 - 134: Diagnosis and Stratification of Hepatocellular CarcinomaByMassimo Colombo;Massimo ColomboA.M. and A. Migliavacca Center for Liver Diseases, 1st Division of Gastroenterology, Fondazione IRCCS Ca’ Granda Maggiore Hospital and University of Milan, Milan, ItalySearch for other works by this author on:Massimo IavaroneMassimo IavaroneA.M. and A. Migliavacca Center for Liver Diseases, 1st Division of Gastroenterology, Fondazione IRCCS Ca’ Granda Maggiore Hospital and University of Milan, Milan, ItalySearch for other works by this author on:
-
135 - 138: Practical Management of Hepatocellular CarcinomaByGregory J. GoresGregory J. GoresDivision of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minn., USASearch for other works by this author on:
